Physician-supervised Semaglutide and Tirzepatide programs with FDA-approved medications (Wegovy®, Ozempic®, Zepbound®, Mounjaro®). Patients in clinical trials lost 15-22% of body weight. Prescribed by United Medical Group physicians. We do not prescribe compounded GLP-1s.
Free eligibility check. No obligation. Takes 5 minutes.
GLP-1 receptor agonists are FDA-approved medications that help regulate appetite and blood sugar, leading to significant weight loss.
The active ingredient in Ozempic and Wegovy. Weekly injection that reduces appetite and helps patients lose an average of 15% body weight.
The active ingredient in Mounjaro and Zepbound. Dual GIP/GLP-1 action for enhanced weight loss, averaging 22% body weight reduction.
Memberships cover physician care and ongoing support. Medication is purchased separately at the manufacturer's direct self-pay price — no markup from us.
Physician care membership. Wegovy®/Ozempic® purchased at manufacturer-direct pricing.
Enhanced physician-care membership with B12, metabolic support, and bi-weekly check-ins.
Dual-action GLP-1/GIP. Zepbound®/Mounjaro® purchased at manufacturer-direct pricing.
Complete our online health questionnaire. We assess your BMI, medical history, and current medications for eligibility.
Schedule a video or phone appointment with a United Medical Group physician to discuss your goals and create a treatment plan.
Your physician e-prescribes to a licensed pharmacy. Medication ships directly to you in discreet packaging.
Regular check-ins with your physician, dose adjustments as needed, and continuous support through our patient portal.
Free eligibility screening. Physician-supervised. Results you can see.
Start Free Screening →